Kernal Biologics, Inc.

Boston, MA

UEI
KBUYMLQEJCE3
CAGE
7PUT6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
15 Necco St fl 7, Boston, MA 02210, USA
Website
kernalbio.com
Founded
2016
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $18,177,254

Contract awards

Award Agency Obligated Awarded
Selective mrna-LNP engineering for cost-effective in situ car t-cell programming 140D042590027 Interior Business Center (DO) $18,177,254

Quick answers

Is Kernal Biologics, Inc. registered in SAM.gov?

Yes. Kernal Biologics, Inc.'s SAM.gov registration is active through November 24, 2026.

How much has Kernal Biologics, Inc. received in federal contracts?

Federal contracts obligated $18,177,254 to Kernal Biologics, Inc. in fiscal year 2025.

How does Kernal Biologics, Inc. rank among federal contractors?

Kernal Biologics, Inc. ranked #17 in PSC AN13 and #47 in PSC AN in FY2025.

What is Kernal Biologics, Inc.'s most recent federal award?

Kernal Biologics, Inc.'s most recent federal contract award is Selective mrna-LNP engineering for cost-effective in situ car t-cell programming (140D042590027), from Interior Business Center (DO), on September 16, 2025.

On GovTribe

See Kernal Biologics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors